Are Molecular Haplotypes Worth the Time and Expense?
Author Information
Author(s): Levenstien Mark A, Ott Jürg, Gordon Derek
Primary Institution: Rockefeller University
Hypothesis
We aim to determine the cost–benefit relationship of increasing the proportion of individuals with molecular haplotype measurements in addition to genotypes to raise the power gain of the LRTae over the LRTstd.
Conclusion
The study suggests that using molecular haplotypes can provide significant power advantages in genetic association studies, especially when the cost of phenotyping is high relative to genotyping.
Supporting Evidence
- Permutation methods maintain the correct type I error.
- Specific multilocus genotypes that are misclassified are consistently misclassified throughout each dataset.
- The LRTae showed a significant power gain over the LRTstd under certain parameter settings.
Takeaway
This study looks at whether spending money on detailed genetic tests called molecular haplotypes is worth it, and finds that it can help researchers find disease links better, especially when other tests are too expensive.
Methodology
The study used simulations to evaluate the performance of two likelihood ratio tests (LRTstd and LRTae) under various scenarios of haplotype misclassification.
Potential Biases
Potential bias due to the assumptions made in the simulation models regarding haplotype frequencies.
Limitations
The study may not account for all types of misclassification and the results are based on simulated data.
Participant Demographics
The study involved simulated datasets with cases and controls, but specific demographic details were not provided.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website